​
​

LakeShore Biopharma (YS) Revenue & Revenue Breakdown

OverviewFinancialsChartTranscripts

LakeShore Biopharma Revenue Highlights

Latest Revenue (Y)

$687.20M

Latest Revenue (Q)

$164.98M

LakeShore Biopharma Revenue by Period

LakeShore Biopharma Revenue by Year

DateRevenueChange
2023-03-31$687.20M36.63%
2022-03-31$502.95M95.69%
2021-03-31$257.02M-

LakeShore Biopharma generated $687.20M in revenue during NA 2023, up 36.63% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

LakeShore Biopharma Revenue by Quarter

DateRevenueChange
2023-12-31$164.98M70.40%
2023-09-30$96.82M-45.08%
2023-06-30$176.27M-2.96%
2022-12-31$181.65M-6.39%
2022-09-30$194.06M-5.56%
2022-06-30$205.48M-

LakeShore Biopharma generated $164.98M in revenue during Q3 2024, up 70.40% compared to the previous quarter, and up 80.29% compared to the same period a year ago.

LakeShore Biopharma Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
YSLakeShore Biopharma$687.20M$164.98M
BDRXBiodexa Pharmaceuticals$381.00K$41.50K
SONNSonnet BioTherapeutics$147.81K-
VRAXVirax Biolabs Group$8.56K$76.50K
CNSPCNS Pharmaceuticals--
ZURAZura Bio--
REVBRevelation Biosciences--
ZVSAZyVersa Therapeutics--
IMMXImmix Biopharma--
ALLRAllarity Therapeutics--
VIRIVirios Therapeutics--
EFTReFFECTOR Therapeutics--
QNRXQuoin Pharmaceuticals--
CDIOCardio Diagnostics-$6.58K

YS Revenue FAQ

What is LakeShore Biopharma’s yearly revenue?

LakeShore Biopharma's yearly revenue for 2023 was $687.2M, representing an increase of 36.63% compared to 2022. The company's yearly revenue for 2022 was $502.95M, representing an increase of 95.69% compared to 2021. YS's yearly revenue for 2021 was $257.02M, representing an increase of 0% compared to 2020.

What is LakeShore Biopharma’s quarterly revenue?

LakeShore Biopharma's quarterly revenue for Q3 2024 was $164.98M, a 70.40% increase from the previous quarter (Q2 2024), and a -14.99% decrease year-over-year (Q2 2023). The company's quarterly revenue for Q2 2024 was $96.82M, a -45.08% decrease from the previous quarter (Q1 2024), and a -52.88% decrease year-over-year (Q1 2023). YS's quarterly revenue for Q1 2024 was $176.27M, a -2.96% decrease from the previous quarter (Q3 2023).

What is LakeShore Biopharma’s revenue growth rate?

LakeShore Biopharma's revenue growth rate for the last 3 years (2021-2023) was 167.38%